Evidence map›Paper›PMID 28572668›Full record

ArticleScientific reports2017

Cathelicidin-trypsin inhibitor loop conjugate represents a promising antibiotic candidate with protease stability.

Haining Yu, Chen Wang, Lan Feng, Shasha Cai, Xuelian Liu, Xue Qiao, Nannan Shi, Hui Wang, Yipeng Wang

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
1.4field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 26 citations in OpenAlex.

  1. Antibacterial action mechanisms and mode of trypsin inhibitors: a systematic review.Journal of enzyme inhibition and medicinal chemistry · 2022
    Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Antimicrobial property ofFood science & nutrition · 2022
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Haining YuSchool of Life Science and Biotechnology, Dalian University of Technology, Dalian, Liaoning, 116024, China. joannyu@live.cn.
Chen WangSchool of Life Science and Biotechnology, Dalian University of Technology, Dalian, Liaoning, 116024, China.
Lan FengSchool of Life Science and Biotechnology, Dalian University of Technology, Dalian, Liaoning, 116024, China.
Shasha CaiSchool of Life Science and Biotechnology, Dalian University of Technology, Dalian, Liaoning, 116024, China.
Xuelian LiuSchool of Life Science and Biotechnology, Dalian University of Technology, Dalian, Liaoning, 116024, China.
Xue QiaoSchool of Life Science and Biotechnology, Dalian University of Technology, Dalian, Liaoning, 116024, China.
Nannan ShiSchool of Life Science and Biotechnology, Dalian University of Technology, Dalian, Liaoning, 116024, China.
Hui WangSchool of Life Science and Biotechnology, Dalian University of Technology, Dalian, Liaoning, 116024, China.
Yipeng WangDepartment of Pharmaceutical Sciences, College of Pharmaceutical Sciences, Soochow University, Suzhou, Jiangsu, 215123, China. yipengwang@suda.edu.cn.
Dalian University of Technology · CNSoochow University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cathelicidins are regarded as promising antibiotics due to their capability against antibiotic-resistant bacteria without cytotoxicity. However, some concerns about the balance of cytotoxicity and antimicrobial activity, weak stability and enzymatic susceptibility sually restrict their therapeutic use. Here, we designed a series of shortened variants, Hc1~15, based on our previously characterized Hc-CATH. Hc3, the one with the best activity, after point mutation was engineered with a trypsin inhibitor loop, ORB-C, to obtain four hybrid peptides: H3TI, TIH3, H3TIF and TIH3F. All four except TIH3 were found possessing an appreciable profile of proteases inhibitory and antimicrobial characteristics without increase in cytotoxicity. Among them, TIH3F exhibited the most potent and broad-spectrum antimicrobial and anti-inflammatory activities. Fluorescence spectroscopy has demonstrated a quick induction of bacterial membrane permeability by TIH3F leading to the cell death, which also accounts for its fast anti-biofilm activity. Such mode of antimicrobial action was mainly attributed to peptides' amphiphilic and helical structures determined by CD and homology modeling. Besides, TIH3F exhibited good tolerance to salt, serum, pH, and temperature, indicating a much better physiological stability in vitro than Hc3, Most importantly, in the case of resistance against proteases hydrolysis, current hybrid peptides displayed a remarkable enhancement than their original templates.

Indexed as

AnimalsAnti-Bacterial AgentsAnti-Infective AgentsBiofilmsCathelicidinsCell Membrane PermeabilityComputer SimulationCytokinesGenetic EngineeringHemolysisInflammation MediatorsMicePeptide HydrolasesPeptidesPoint MutationProtein ConformationAnti-Bacterial AgentsAnti-Infective AgentsCathelicidinsCytokinesInflammation MediatorsPeptide HydrolasesPeptidesTrypsin Inhibitors

Identifiers

PMID28572668
PMCPMC5453931
OpenAlexW2617435406

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.